The Use of a Prescription Drug Monitoring Program to Develop Algorithms to Identify Providers With Unusual Prescribing Practices for Controlled Substances

2015 ◽  
Vol 36 (5) ◽  
pp. 287-299 ◽  
Author(s):  
Christopher Ringwalt ◽  
Sharon Schiro ◽  
Meghan Shanahan ◽  
Scott Proescholdbell ◽  
Harold Meder ◽  
...  
Author(s):  
Sylvia May ◽  
Chris Baumgartner ◽  
Gary Garrety ◽  
Heidi McLaughlin

There are over 700 prescription and illicit opioid-related deaths each year in Washington State. Integrating the Prescription Drug Monitoring Program (PDMP) data into the electronic health record (EHR) allows providers seamless access to patient controlled substances prescription histories, thereby reducing inappropriate prescribing and overdoses. The project overview describes the study focus, investigation of barriers to integrating PDMP data into EHRs across care settings for providers in Washington State who prescribe controlled substances. An online survey tool was developed to inquire about barriers to PDMP integration. The article presents survey results, indicating that 81% of respondents were not integrating PMDP data into the EHR and 52% did not plan on integration. The discussion section considers common barriers that providers identified, such as EHR vendor inability to provide an update, difficulty accessing the PDMP, and prioritization. Cost was the most significant barrier. Discovering barriers to PDMP integration allows stakeholders to address these issues and prevent overprescribing of controlled substances.


2018 ◽  
Vol 4 (2) ◽  
pp. 178-186 ◽  
Author(s):  
J.L. McCauley ◽  
G.H. Gilbert ◽  
D.L. Cochran ◽  
V.V. Gordan ◽  
R.S. Leite ◽  
...  

Introduction: The American Dental Association recommends that dentists use a prescription drug monitoring program (PDMP) prior to prescribing an opioid for acute pain management. Objective: The objective of this study was to examine dentists’ experiences using their state PDMP, as well as the impact that state-mandated registration policies, mandated use policies, and practice characteristics had on the frequency with which dentists used their PDMP. Methods: We conducted a web-based cross-sectional survey among practicing dentist members of the National Dental Practice-Based Research Network ( n = 805). The survey assessed prescribing practices for pain management and implementation of risk mitigation strategies, including PDMP use. Survey data were linked with network Enrollment Questionnaire data to include practitioner demographics and practice characteristics. Results: Nearly half of respondents ( n = 375, 46.6%) reported having never accessed a PDMP, with the most common reasons for nonaccess being lack of awareness ( n = 214, 57.1%) and lack of knowledge regarding registration and use ( n = 94, 25.1%). The majority of PDMP users reported the program to be very helpful (58.1%) or somewhat helpful (31.6%). Dentists reported that PDMP use most often did not change their intended prescribing behavior (40.2%), led them not to prescribe an opioid (33.5%), or led them to prescribe fewer opioid doses (25.5%). Presence of a mandated use policy was significantly associated with increased frequency of PDMP use across a variety of situations, including prior to 1) prescribing any opioid for pain management, 2) issuing refills, 3) prescribing to new patients, and 4) prescribing to patients deemed high risk. Conclusion: Findings suggest that the majority of dentists find PDMPs helpful in informing their opioid-prescribing practices. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study. Knowledge Transfer Statement: Findings from this national survey suggest that the majority of practicing dentists find PDMPs helpful in informing their opioid-prescribing practices; however, consistent PDMP use was not common. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study.


Author(s):  
Someshwar D. Mankar ◽  
Abhijit S. Navale ◽  
Suraj R. Kadam

Nowadays Prescription Opioid Abuse has become a serious problem, to monitor and reduce Opioid Abuse most of countries developed Prescription Drug Monitoring Program (PDMP). Regarding to this we conduct a systematic review to understanding the PDMP impact in order to reduce Opioid Abuse and improving prescriber practices. This review can help to guide efforts to better response to the Opioid crises.


Pain Medicine ◽  
2016 ◽  
Vol 17 (11) ◽  
pp. 2061-2066 ◽  
Author(s):  
Christi Hildebran ◽  
Gillian Leichtling ◽  
Jessica M. Irvine ◽  
Deborah J. Cohen ◽  
Sara E. Hallvik ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document